Barclays’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-93
Closed -$11K 6332
2015
Q4
$11K Sell
93
-1,309
-93% -$158K ﹤0.01% 5372
2015
Q3
$72K Buy
1,402
+561
+67% +$30.8K ﹤0.01% 4813
2015
Q2
$50K Sell
841
-16,684
-95% -$1M ﹤0.01% 5138
2015
Q1
$1.05M Sell
17,525
-21,591
-55% -$1.19M ﹤0.01% 2933
2014
Q4
$2.09M Sell
39,116
-114,263
-74% -$5.76M ﹤0.01% 2495
2014
Q3
$7.22M Buy
153,379
+149,874
+4,276% +$6.76M 0.01% 1439
2014
Q2
$155K Sell
3,505
-701
-17% -$27.5K ﹤0.01% 5065
2014
Q1
$168K Sell
4,206
-2,804
-40% -$115K ﹤0.01% 4951
2013
Q4
$285K Buy
7,010
+3,785
+117% +$154K ﹤0.01% 4648
2013
Q3
$133K Buy
3,225
+982
+44% +$41.3K ﹤0.01% 5389
2013
Q2
$95K Buy
+2,243
New +$93.9K ﹤0.01% 5832

Other funds holding MSGS

Barclays's MSGS Position: Q2 2026 in Review

Barclays reduced its Madison Square Garden (MSGS) stake by 1.2% in Q2 2026, selling an estimated $76.1K and leaving 17,693 shares worth $7.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1658.

Barclays first reported a position in MSGS in Q2 2013 and has held it in 53 quarters since. The position peaked at $26.4M in Q1 2015. 469 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

  • Barclays held 17,693 shares of Madison Square Garden worth $7.11M as of Q2 2026.
  • Barclays sold 215 Madison Square Garden shares in Q2 2026, an estimated $76.1K.
  • Madison Square Garden made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1658 holding.
  • Barclays first reported a position in Madison Square Garden in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Madison Square Garden position peaked at $26.4M in Q1 2015.
  • 469 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.